{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:31:14Z","timestamp":1761766274826,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-15-00904"],"award-info":[{"award-number":["14-15-00904"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12888-017-1562-1","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T12:42:14Z","timestamp":1512736934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines"],"prefix":"10.1186","volume":"17","author":[{"given":"A. E.","family":"Taraskina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. F.","family":"Nasyrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Zabotina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. N.","family":"Sosin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u041a. \u0410.","family":"Sosina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. E.","family":"Ershov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. N.","family":"Grunina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. M.","family":"Krupitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"1562_CR1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","volume":"4","author":"AD Lopez","year":"1998","unstructured":"Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4:1241\u20133.","journal-title":"Nat Med"},{"key":"1562_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpsyc.1973.01750320023004","volume":"28","author":"DS Janowsky","year":"1973","unstructured":"Janowsky DS, El-Yousel MK, Davis JM, et al. Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry. 1973;28:185\u201391.","journal-title":"Arch Gen Psychiatry"},{"key":"1562_CR3","first-page":"200","volume":"32","author":"S Matthysse","year":"1973","unstructured":"Matthysse S. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia. Fed Proc. 1973;32:200\u20138.","journal-title":"Fed Proc"},{"key":"1562_CR4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1126\/science.1066969","volume":"294","author":"A Carlsson","year":"2001","unstructured":"Carlsson A. A paradigm shift in brain research. Science. 2001;294:1021\u20134.","journal-title":"Science"},{"key":"1562_CR5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2990.2010.01128.x","volume":"37","author":"I Zhan","year":"2011","unstructured":"Zhan I, Kerr JR, Lafuente MJ, et al. Altered expression and coregulation of dopamine signaling genes in schizophrenia and bipolar disorder. Neuropathol Appl Neurobiol. 2011;37:206\u201319.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1562_CR6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.109.066217","volume":"196","author":"NA Crossley","year":"2010","unstructured":"Crossley NA, Constante M, McGuire P, et al. Efficacy of atypical v. Typical antipsychotics in the treatment of early psychosis: meta-analysis. Br J Psychiatry. 2010;196:434\u20139.","journal-title":"Br J Psychiatry"},{"key":"1562_CR7","doi-asserted-by":"crossref","first-page":"656370","DOI":"10.1155\/2014\/656370","volume":"2014","author":"N Divac","year":"2014","unstructured":"Divac N, Prostran M, Jakovcevski I, et al. Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int. 2014;2014:656370.","journal-title":"Biomed Res Int"},{"key":"1562_CR8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.euroneuro.2016.01.009","volume":"26","author":"DC Goff","year":"2016","unstructured":"Goff DC, Romero K, Paul J, et al. Biomarkers for drug development in early psychosis: current issues and promising directions. Eur Neuropsychopharmacology. 2016;26:923\u201337.","journal-title":"Eur Neuropsychopharmacology"},{"key":"1562_CR9","first-page":"2","volume":"26","author":"F Thibaut","year":"2014","unstructured":"Thibaut F. Acute treatment of schizophrenia: introduction to the word Federation of Societies of biological psychiatry guidelines. Psychiatr Danub. 2014;26:2\u201311.","journal-title":"Psychiatr Danub"},{"issue":"1","key":"1562_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5498\/wjp.v6.i1.102","volume":"6","author":"C-Y Lai","year":"2016","unstructured":"Lai C-Y, Scarr E, Udawela M, et al. Biomarkers in schizophrenia: a focus on blood based diagnostics and theranostics. World J of Psychiatr. 2016;6(1):102\u201317.","journal-title":"World J of Psychiatr"},{"key":"1562_CR11","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1073\/pnas.91.26.12912","volume":"91","author":"J Bergquist","year":"1994","unstructured":"Bergquist J, Tarkowski A, Ekman R, et al. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A. 1994;91:12912\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1562_CR12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/157015911795596612","volume":"9","author":"FR Buttarelli","year":"2011","unstructured":"Buttarelli FR, Fanciulli A, Pellicano C, et al. The dopamine system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders. Curr Neuropharmacol. 2011;9:278\u201388.","journal-title":"Curr Neuropharmacol"},{"key":"1562_CR13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","volume":"132","author":"F McKenna","year":"2002","unstructured":"McKenna F, McLaughlin PJ, Lewis BJ, et al. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol. 2002;132:34\u201340.","journal-title":"J Neuroimmunol"},{"key":"1562_CR14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jneumeth.2008.07.018","volume":"174","author":"GP Kirillova","year":"2008","unstructured":"Kirillova GP, Hrutkay RJ, Shurin MR, et al. Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays. J Neurosci Methods. 2008;174:272\u201380.","journal-title":"J Neurosci Methods"},{"issue":"3","key":"1562_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/1872213X08666141016145012","volume":"8","author":"H Sheikhha","year":"2014","unstructured":"Sheikhha H, Emadi S, Jorbozedar S, et al. Investigation of gene expression pattern of 5HTR2a and MAO-a in PBMCs of individuals who had been exposed to air pollution in highly polluted area. Recent Patents Inflamm Allergy Drug Discov. 2014;8(3):203\u201310.","journal-title":"Recent Patents Inflamm Allergy Drug Discov"},{"issue":"9","key":"1562_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2004.08.008","volume":"56","author":"UM D\u2019Souza","year":"2004","unstructured":"D\u2019Souza UM, Russ C, Tahir E, et al. Functional effects of a tandem duplication polymorphism in the 5\u2019flanking region of the DRD4 gene. Biol Psychiatry. 2004;56(9):691\u20137.","journal-title":"Biol Psychiatry"},{"key":"1562_CR17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2005.11.018","volume":"173","author":"EM Boneberg","year":"2006","unstructured":"Boneberg EM, von Seydlitz E, Propster K, et al. D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD+\u2212T cells. J Neuroimmunol. 2006;173:180\u20137.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"1562_CR18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eurpsy.2013.12.002","volume":"29","author":"P Grant","year":"2014","unstructured":"Grant P, Gabriel F, Kuepper Y, et al. Psychosis-proneness correlates with expression levels of dopaminergic genes. Eur Psychiatry. 2014;29(5):304\u20136.","journal-title":"Eur Psychiatry"},{"key":"1562_CR19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.171","volume":"40","author":"NC Allen","year":"2008","unstructured":"Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene data-base. Nat Genet. 2008;40:827\u201334.","journal-title":"Nat Genet"},{"key":"1562_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-9964(03)00183-X","volume":"67","author":"HM Abdolmaleky","year":"2004","unstructured":"Abdolmaleky HM, Faraone SV, Glatt SJ, et al. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res. 2004;67:53\u201362.","journal-title":"Schizophr Res"},{"issue":"2","key":"1562_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.psychres.2010.11.003","volume":"188","author":"HL Cai","year":"2011","unstructured":"Cai HL, Fang PF, Li HD, et al. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment. Psychiatry Res. 2011;188(2):197\u2013202.","journal-title":"Psychiatry Res"},{"unstructured":"WHO: International statistical classification of diseases and related health problems (ICD-10) \u2013 10th revision. Geneva: World Organization; 2011.","key":"1562_CR22"},{"key":"1562_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (pans) for schizophrenia. Schizophrenia Bull. 1987;13:261.","journal-title":"Schizophrenia Bull"},{"doi-asserted-by":"crossref","unstructured":"Guy W, Nair TR, Christensen JD, et al. Clinical global impression (CGI). Assessment manual for Psychopharmacology. 1976:125\u20136.","key":"1562_CR24","DOI":"10.1037\/e591322011-001"},{"issue":"Suppl. 44","key":"1562_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"SG Simpson","year":"1970","unstructured":"Simpson SG, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand. 1970;212(Suppl. 44):11\u20139.","journal-title":"Acta Psychiatr Scand"},{"unstructured":"Smith RM, Papp AC, Webb A, et al. Multiple regulatory variants modulate expression of 5-Hydroxytryptamine 2A receptors in human cortex. J of Psychiatr Neuroscience and Therapeutics. 2013;73, 546(Is.6):\u2013554.","key":"1562_CR26"},{"key":"1562_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-244X-4-12","volume":"4","author":"R Apiquian","year":"2004","unstructured":"Apiquian R, Fresan A, De la Fuente-Sandoval C, et al. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns. BMC Psychiatry. 2004;4:12.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"1562_CR28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hup.2542","volume":"31","author":"M Buoli","year":"2016","unstructured":"Buoli M, Kahn RS, Serati M, et al. Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia. Hum Psychopharmacol. 2016;31(4):325\u201331.","journal-title":"Hum Psychopharmacol"},{"issue":"8","key":"1562_CR29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2215-0366(16)00085-7","volume":"3","author":"G Grunder","year":"2016","unstructured":"Grunder G, Heinze M, Cordes J, et al. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomized study. Lancet Psychiatry. 2016;3(8):717\u201329.","journal-title":"Lancet Psychiatry"},{"key":"1562_CR30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1192\/bjp.185.6.452","volume":"185","author":"SP Singh","year":"2004","unstructured":"Singh SP, Burns T, Amin S, et al. Acbte andv transient psychotic disorders: precursors, epidemiology, course and outcome. Br J Psychiatry J Ment Sci. 2004;185:452\u20139.","journal-title":"Br J Psychiatry J Ment Sci"},{"issue":"4","key":"1562_CR31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ajmg.b.31062","volume":"153B","author":"B Rollins","year":"2010","unstructured":"Rollins B, Martin MV, Morgan L, et al. Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(4):919\u201336.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1562_CR32","doi-asserted-by":"crossref","first-page":"26677","DOI":"10.3390\/ijms161125983","volume":"16","author":"Y Cui","year":"2015","unstructured":"Cui Y, Prabhu V, Nguyen TB, et al. The mRNA expression status of dopamine receptor D2, dopamine receptor D3 and DARPP-32 in T lymphocytes of patients with early psychosis. Int J Mol Sci. 2015;16:26677\u201386.","journal-title":"Int J Mol Sci"},{"key":"1562_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-2-3","volume":"2","author":"YT Kwak","year":"2001","unstructured":"Kwak YT, Koo MS, Choi CH, et al. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med Genet. 2001;2:3.","journal-title":"BMC Med Genet"},{"issue":"15","key":"1562_CR34","first-page":"273","volume":"6","author":"AE Taraskina","year":"2012","unstructured":"Taraskina AE, Morozova MN, Bichkova NV, et al. The quanitity of lymphocytes expressing D2-like dopamine receptors in patients with a alcohol dependence and health (in russian). Russian Journal of immunology. 2012;6(15):273\u201380.","journal-title":"Russian Journal of immunology"},{"key":"1562_CR35","doi-asserted-by":"crossref","first-page":"e75259","DOI":"10.1371\/journal.pone.0075259","volume":"8","author":"L Liu","year":"2013","unstructured":"Liu L, Yuan G, Cheng Z, et al. Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients. PLoS One. 2013;8:e75259.","journal-title":"PLoS One"},{"issue":"6","key":"1562_CR36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jpsychires.2012.03.004","volume":"46","author":"GE Brito-Melo","year":"2012","unstructured":"Brito-Melo GE, Nicolato R, de Oliveira AC, et al. Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity. J Psychiatr Res. 2012;46(6):738\u201342.","journal-title":"J Psychiatr Res"},{"issue":"12","key":"1562_CR37","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/jcb.24883","volume":"115","author":"AG Paquette","year":"2014","unstructured":"Paquette AG, Marsit CJ. The developmental basis of epigenetic regulation of HTR2A and psychiatric outcomes. J Cell Biochem. 2014;115(12):2065\u201372.","journal-title":"J Cell Biochem"},{"issue":"9","key":"1562_CR38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jamapsychiatry.2013.1378","volume":"70","author":"G Blasi","year":"2013","unstructured":"Blasi G, De Virgilio C, Parazacharias A, et al. Converging evidence for the association of funtional genetic variation in the serotonin receptor 2a gene with prefrontal function and olanzapine treatment. JAMA Psychiatry. 2013;70(9):921\u201330.","journal-title":"JAMA Psychiatry"},{"key":"1562_CR39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-244X-8-40","volume":"8","author":"D Benmessaoud","year":"2008","unstructured":"Benmessaoud D, Hamdani N, Boni C, et al. Excess of transmission of the G allele of the -1438A\/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics. BMC Psychiatry. 2008;8:40.","journal-title":"BMC Psychiatry"},{"issue":"6","key":"1562_CR40","first-page":"9943","volume":"8","author":"M Liu","year":"2015","unstructured":"Liu M, Luo J. Relatioship between peripheral blood dopamine level andb internet addiction disorder in adolescents: a pilot study. Int J Clin Exp Med. 2015;8(6):9943\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"1562_CR41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000431155","volume":"5","author":"M Moussouttas","year":"2015","unstructured":"Moussouttas M, Mearns E, Walters A, et al. Plasma catecholamine profile of subarachnoid hemorrhage patients with neurogenic cardiomyopathy. Cerebrovasc Dis Extra. 2015;5:57\u201367.","journal-title":"Cerebrovasc Dis Extra"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-017-1562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T15:00:17Z","timestamp":1719673217000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-017-1562-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1562"],"URL":"https:\/\/doi.org\/10.1186\/s12888-017-1562-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"394"}}